Clinical studies in spinal cord injury: moving towards successful trials.
Spinal cord injury is a devastating condition for which there is still no cure. Many new therapies have emerged in the past few decades that have attempted to improve the outcome after injury, with varying levels of supporting experimental and clinical data. Most studies have been preliminary and have lacked control groups, but positive results can often be embraced by clinicians and patients who are faced without an alternative, despite the poor design and bias of many studies. This article is a review of clinical studies in spinal cord injury and discusses guidelines for future clinical trial design.
Knafo
S
S
Institute of Neurology, University College London, London, UK.
Choi
D
D
D015761:4-Aminopyridine / Q000627:therapeutic use*; D000818:Animals; D035843:Biomedical Research / Q000193:education* / Q000639:trends; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D051381:Rats; D020127:Recovery of Function / Q000187:drug effects*; D012107:Research Design; D013119:Spinal Cord Injuries / Q000150:complications / Q000534:rehabilitation*; D016896:Treatment Outcome
D026902:Potassium Channel Blockers; D015761:4-Aminopyridine